# Daxor Corporation (DXR)

> Source: Nexqual · https://nexqual.com/DXR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Daxor Corporation (DXR), nexqual.com/DXR" · informational, not investment advice.

**Price:** USD 10.2 (+1.75% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 10.03 · day 10.08–10.36 · 52w 8.56–14.76 · market cap $59.5M · NCM

## Key facts
- Analysts: Buy (mean 1.50 on a 1–5 scale) (2 analysts), mean target USD 20 (range 18–22).
- Total return with dividends: 1Y -21.5% vs S&P 500 +18.1%; 5Y -9.3% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 1.50 on a 1–5 scale), 2 analysts; mean target USD 20 (low 18, high 22).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -21.5% | -9.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -21.6% | -1.9% |
| Volatility (annualized) | 50.5% | 37.4% |
| Max drawdown | -39.9% (Dec 2025→Apr 2026) | -48.6% (Jul 2022→Feb 2025) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.68 +6.34% · XRAY (DENTSPLY SIRONA Inc.) USD 8.83 +3.76% · LMAT (LeMaitre Vascular, Inc.) USD 83.16 +1.97% · ATRC (AtriCure, Inc.) USD 57.78 +1.60% · WRBY (Warby Parker Inc.) USD 24.59 -7.28% · PLSE (Pulse Biosciences, Inc) USD 45.59 -6.08%

## More
Full page: https://nexqual.com/DXR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt